Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers

Diabetes Care. 2007 Feb;30(2):370-1. doi: 10.2337/dc06-2348.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / therapeutic use
  • Aged
  • Animals
  • Diabetic Foot / drug therapy
  • Diabetic Foot / microbiology*
  • Diabetic Foot / therapy*
  • Diabetic Neuropathies / physiopathology
  • Foot Ulcer / microbiology
  • Foot Ulcer / therapy*
  • Humans
  • Larva*
  • Linezolid
  • Methicillin Resistance*
  • Middle Aged
  • Oxazolidinones / therapeutic use
  • Patient Selection
  • Reproducibility of Results
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / isolation & purification*
  • Vancomycin / therapeutic use

Substances

  • Acetamides
  • Oxazolidinones
  • Vancomycin
  • Linezolid